These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38965304)

  • 1. High levels of high-density lipoprotein cholesterol may increase the risk of diabetic kidney disease in patients with type 2 diabetes.
    Wang H; Wu J; Lin M; Hu Y; Ma Y
    Sci Rep; 2024 Jul; 14(1):15362. PubMed ID: 38965304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The threshold effect of triglyceride glucose index on diabetic kidney disease risk in patients with type 2 diabetes: unveiling a non-linear association.
    Wang H; Chen G; Sun D; Ma Y
    Front Endocrinol (Lausanne); 2024; 15():1411486. PubMed ID: 38938513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in China: Findings from the China Cardiometabolic Disease and Cancer Cohort (4C) Study.
    Gong L; Wang C; Ning G; Wang W; Chen G; Wan Q; Qin G; Yan L; Wang G; Qin Y; Luo Z; Tang X; Huo Y; Hu R; Ye Z; Shi L; Gao Z; Su Q; Mu Y; Zhao J; Chen L; Zeng T; Yu X; Li Q; Shen F; Zhang Y; Wang Y; Deng H; Liu C; Wu S; Yang T; Bi Y; Lu J; Li M; Xu Y; Xu M; Wang T; Zhao Z; Hou X; Chen L
    Diabetes Obes Metab; 2021 Nov; 23(11):2551-2560. PubMed ID: 34322974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
    Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
    Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative.
    Russo GT; De Cosmo S; Viazzi F; Pacilli A; Ceriello A; Genovese S; Guida P; Giorda C; Cucinotta D; Pontremoli R; Fioretto P;
    Diabetes Care; 2016 Dec; 39(12):2278-2287. PubMed ID: 27703024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric Acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese population.
    Yan D; Tu Y; Jiang F; Wang J; Zhang R; Sun X; Wang T; Wang S; Bao Y; Hu C; Jia W
    PLoS One; 2015; 10(6):e0129797. PubMed ID: 26029914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China.
    Yang H; Young D; Gao J; Yuan Y; Shen M; Zhang Y; Duan X; Zhu S; Sun X
    Lipids Health Dis; 2019 Jan; 18(1):18. PubMed ID: 30658647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between lactate dehydrogenase and the risk of diabetic kidney disease in patients with type 2 diabetes.
    Tang L; Yang Q; Ma R; Zhou P; Peng C; Xie C; Liang Q; Wu T; Gao W; Yu H; Deng G; Dai Z; Mao N; Xiao X
    Front Endocrinol (Lausanne); 2024; 15():1369968. PubMed ID: 38567310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing screening tools to estimate the risk of diabetic kidney disease in patients with type 2 diabetes mellitus.
    Cao X; Pei X
    Technol Health Care; 2024; 32(3):1807-1818. PubMed ID: 37980579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes.
    Yan H; Zhou Q; Wang Y; Tu Y; Zhao Y; Yu J; Chen K; Hu Y; Zhou Q; Zhang W; Zheng C
    Cardiovasc Diabetol; 2024 Apr; 23(1):142. PubMed ID: 38664793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl Ester Transfer Protein Genetic Variants Associated with Risk for Type 2 Diabetes and Diabetic Kidney Disease in Taiwanese Population.
    Huang YC; Chen SY; Liu SP; Lin JM; Lin HJ; Lei YJ; Chung YC; Chen YC; Wang YH; Liao WL; Tsai FJ
    Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31597401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between hemoglobin glycation index and diabetic kidney disease in type 2 diabetes mellitus in China: A cross- sectional inpatient study.
    Xin S; Zhao X; Ding J; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1108061. PubMed ID: 36967789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients.
    Hanai K; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Bouchi R; Tanaka N; Ishii A; Iwamoto Y
    Nephrol Dial Transplant; 2012 Mar; 27(3):1070-5. PubMed ID: 21785041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remnant Cholesterol and Cardiovascular Mortality in Patients With Type 2 Diabetes and Incident Diabetic Nephropathy.
    Yu D; Wang Z; Zhang X; Qu B; Cai Y; Ma S; Zhao Z; Simmons D
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3546-3554. PubMed ID: 34291804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of the Relationships Between Multiple Lipid Indices and Diabetic Kidney Disease in Patients With Type 2 Diabetes: A Cross-Sectional Study.
    Lu CF; Liu WS; Chen ZH; Hua LY; Wang XQ; Huang HY
    Front Endocrinol (Lausanne); 2022; 13():888599. PubMed ID: 35873008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A J-shaped relationship between ketones and the risk of diabetic kidney disease in patients with type 2 diabetes: New insights from a cross-sectional study.
    Liu Y; Wang J; Xu F; Zhang S; Cui S; Li Y; Wang X; Zheng H; Li J; Kong Y; Yang J; Jiang X; Chang B
    Diabetes Obes Metab; 2023 Nov; 25(11):3317-3326. PubMed ID: 37608468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-peptide, glycaemic control, and diabetic complications in type 2 diabetes mellitus: A real-world study.
    Huang Y; Wang Y; Liu C; Zhou Y; Wang X; Cheng B; Kui C; Wang Y
    Diabetes Metab Res Rev; 2022 May; 38(4):e3514. PubMed ID: 34841643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
    Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
    Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.